Skip to main content
Premium Trial:

Request an Annual Quote

Amersham is Granted Favorable Ruling Over PE

Premium

FOSTER CITY, Calif.--Nycomed Amersham last week said its life science unit, Amersham Pharma-cia Biotech, was granted two favorable rulings by a California District Court in its intellectual property action against PE Biosys-tems. The lawsuit relates to use of energy transfer dyes that are used to enable high throughput DNA sequencing. Amersham, which licenses rights to US Patent No. 5,688,648 from the University of California, Berkeley, anticipated that the case would come to trial in January 2001. PE Biosystems contended that Amersham’s claims are invalid because of prior technical work published by others. PE also has a suit against Amersham relating to Amersham’s MegaBACE DNA sequencing instrument.

Filed under

The Scan

Rise of BA.5

The New York Times reports that the Omicron subvariant BA.5 has become the dominant version of SARS-CoV-2 in the US.

UK Health Secretary Resigns

Sajid Javid, the UK health secretary, resigned along with Chancellor Rishi Sunak, saying they cannot work with Prime Minister Boris Johnson's government, CNN reports.

Clones From Freeze-Dried Cells

A team in Japan has cloned mice from freeze-dried skin cells, according to the Guardian.

Genome Research Papers on Craniosynostosis, Macaque Retrotransposition, More

In Genome Research this week: structural variants in craniosynostosis, LINE-1 activity in rhesus macaque brain, and more.